Cargando…
Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997801/ https://www.ncbi.nlm.nih.gov/pubmed/33009516 http://dx.doi.org/10.1038/s41397-020-00193-6 |
| _version_ | 1783670408895004672 |
|---|---|
| author | Guberina, Maja Sak, Ali Pöttgen, Christoph Tinhofer-Keilholz, Ingeborg Budach, Volker Balermpas, Panagiotis Von der Grün, Jens Rödel, Claus Michael Gkika, Eleni Grosu, Anca-Ligia Abdollahi, Amir Debus, Jürgen Belka, Claus Pigorsch, Steffi Combs, Stephanie E. Mönnich, David Zips, Daniel De-Colle, Chiara Welz, Stefan Linge, Annett Lohaus, Fabian Baretton, Gustavo Gauler, Thomas Baumann, Michael Krause, Mechthild Schuler, Martin Bankfalvi, Agnes Höing, Benedikt Lang, Stephan Stuschke, Martin |
| author_facet | Guberina, Maja Sak, Ali Pöttgen, Christoph Tinhofer-Keilholz, Ingeborg Budach, Volker Balermpas, Panagiotis Von der Grün, Jens Rödel, Claus Michael Gkika, Eleni Grosu, Anca-Ligia Abdollahi, Amir Debus, Jürgen Belka, Claus Pigorsch, Steffi Combs, Stephanie E. Mönnich, David Zips, Daniel De-Colle, Chiara Welz, Stefan Linge, Annett Lohaus, Fabian Baretton, Gustavo Gauler, Thomas Baumann, Michael Krause, Mechthild Schuler, Martin Bankfalvi, Agnes Höing, Benedikt Lang, Stephan Stuschke, Martin |
| author_sort | Guberina, Maja |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7997801 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79978012021-04-12 Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy Guberina, Maja Sak, Ali Pöttgen, Christoph Tinhofer-Keilholz, Ingeborg Budach, Volker Balermpas, Panagiotis Von der Grün, Jens Rödel, Claus Michael Gkika, Eleni Grosu, Anca-Ligia Abdollahi, Amir Debus, Jürgen Belka, Claus Pigorsch, Steffi Combs, Stephanie E. Mönnich, David Zips, Daniel De-Colle, Chiara Welz, Stefan Linge, Annett Lohaus, Fabian Baretton, Gustavo Gauler, Thomas Baumann, Michael Krause, Mechthild Schuler, Martin Bankfalvi, Agnes Höing, Benedikt Lang, Stephan Stuschke, Martin Pharmacogenomics J Correction Nature Publishing Group UK 2020-10-02 2021 /pmc/articles/PMC7997801/ /pubmed/33009516 http://dx.doi.org/10.1038/s41397-020-00193-6 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correction Guberina, Maja Sak, Ali Pöttgen, Christoph Tinhofer-Keilholz, Ingeborg Budach, Volker Balermpas, Panagiotis Von der Grün, Jens Rödel, Claus Michael Gkika, Eleni Grosu, Anca-Ligia Abdollahi, Amir Debus, Jürgen Belka, Claus Pigorsch, Steffi Combs, Stephanie E. Mönnich, David Zips, Daniel De-Colle, Chiara Welz, Stefan Linge, Annett Lohaus, Fabian Baretton, Gustavo Gauler, Thomas Baumann, Michael Krause, Mechthild Schuler, Martin Bankfalvi, Agnes Höing, Benedikt Lang, Stephan Stuschke, Martin Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy |
| title | Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy |
| title_full | Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy |
| title_fullStr | Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy |
| title_full_unstemmed | Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy |
| title_short | Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy |
| title_sort | correction: ercc2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997801/ https://www.ncbi.nlm.nih.gov/pubmed/33009516 http://dx.doi.org/10.1038/s41397-020-00193-6 |
| work_keys_str_mv | AT guberinamaja correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT sakali correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT pottgenchristoph correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT tinhoferkeilholzingeborg correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT budachvolker correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT balermpaspanagiotis correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT vondergrunjens correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT rodelclausmichael correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT gkikaeleni correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT grosuancaligia correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT abdollahiamir correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT debusjurgen correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT belkaclaus correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT pigorschsteffi correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT combsstephaniee correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT monnichdavid correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT zipsdaniel correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT decollechiara correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT welzstefan correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT lingeannett correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT lohausfabian correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT barettongustavo correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT gaulerthomas correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT baumannmichael correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT krausemechthild correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT schulermartin correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT bankfalviagnes correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT hoingbenedikt correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT langstephan correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy AT stuschkemartin correctionercc2genesinglenucleotidepolymorphismasaprognosticfactorforlocallyadvancedheadandneckcarcinomasafterdefinitivecisplatinbasedradiochemotherapy |